Company news

Vivoryon Therapeutics N.V. news in 2026

Vivoryon Therapeutics N.V.'s news releases, calls and decks from 2026, newest first.

View company

Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update

November 5, 2026

Vivoryon Therapeutics N.V. Reports Outcome of 2026 Annual General Meeting

September 29, 2026

Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026

August 18, 2026

Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update

August 6, 2026

Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026, Annual General Meeting Planned for End of September 2026

July 23, 2026

Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026

July 22, 2026

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update

June 11, 2026

Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026

June 8, 2026

Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update

April 23, 2026

Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026

April 15, 2026

Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference

April 9, 2026

Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology

March 28, 2026

Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences

January 7, 2026

Calls in 2026

Decks in 2026